This study assesses the frequency of continuation patents on brand-name drugs approved by the US Food and Drug Administration from 2000 to 2015.
No takes yet. Share an insight, caveat, or question.
Tu et al. (2023) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: